Skip to main content

Table 3 Association of different variables with BRCA1/2 mutation status, N=95a

From: Germline BRCA1/BRCA2 mutations among high risk breast cancer patients in Jordan

Variable

Level

Total

BRCA1/2 mutation status

P-value

Positive (deleterious and suspected deleterious)

Others (No variant, FP, VUS)

Age N = 95

age < =40

50

13(26.0%)

37(74.0%)

NS

 

age > 40

45

9(20.0%)

36 (80.0%)

 

Triple negative N = 95

No

79

13 (16.5%)

66 (83.5%)

0.001

Yes

16

9 (56.3%)

7 (43.8%)

 

Triple negative (age < =50 (N = 75))

No

60

12 (20.0%)

48 (80.0%)

 

Yes

15

8 (53.3%)

7 (46.7%)

0.009

Triple negative (age < =40 (N = 50))

No

38

7 (18.4%)

31 (81.6%)

 

Yes

12

6 (50.0%)

6 (50.0%)

0.030

Triple negative (family history = Yes (N = 84))

No

71

13 (18.3%)

58 (81.7%)

 

Yes

13

9 (69.2%)

4 (30.8%)

0.000

Number of relatives with breast and/or ovarian cancer (first and second degree)

Relatives < 2

31

4 (12.9%)

27 (87.1%)

NS

Relatives > = 2

64

18 (28.1%)

46 (71.9%)

 

Family history of breast cancer and/or ovarian cancer (first and second degree)

No

11

 

11(100%)

0.063

Yes

84

22 (26.2%)

62 (73.8%)

 

Bilateral or second primary breast cancer

no

80

12 (15.0%)

68 (85.0%)

0.000

yes

15

10 (66.7%)

5 (33.3%)

 

Family history of male breast cancer

no

90

20 (22.2%)

70 (77.8%)

NS

yes

5

2 (40.0%)

3 (60.0%)

 

Family history (age < =40 (N = 50))

No

10

 

10(100%)

0.046

Yes

40

13 (32.5%)

27 (67.5%)

 
  1. FP favor polymorphism, VUS variant of uncertain significance, NS non-significant
  2. aFive patients (patients 061, 063, 020, 070 and 071) were relatives to the index case tested in their families, therefore they were excluded from this analysis, see footnote to Table 2